Sialic Acid-Mimic Peptides As Hemagglutinin Inhibitors for Anti-Influenza Therapy
Sialic Acid-Mimic Peptides As Hemagglutinin Inhibitors for Anti-Influenza Therapy
复制标题
DOI:
10.1021/jm1002183
复制
发表时间:
2010-06-10
影响因子:
7.3
通讯作者:
Sato, Toshinori
中科院分区:
文献类型:
--
作者:
Matsubara, Teruhiko;Onishi, Ai;Sato, Toshinori
Influenza is an infectious disease caused by the influenza virus, and each year many people suffer from this disease. Hemagglutinin (HA) in the membrane of type A influenza viruses recognizes sialylglyco-conjugate receptors on the host cell surface at an initial step in the infection process; consequently, HA inhibitors are considered potential candidates for antiviral drugs. We identified peptides that bind to receptor-binding sites through a multiple serial selection from phage-displayed random peptide libraries. Using the HA of the H1 and H3 strains as target proteins, we obtained peptides that bind to both H As. The binding affinities of peptides for these H As were improved by secondary and tertiary selections from the corresponding sublibraries. A docking simulation suggested that, similar to sialic acid, the peptides are recognized by the receptor-binding site in HA, which indicates that these peptides mimic the sialic acid structure. N-stearoyl peptides inhibited infections by the A/Puerto Rico/8/34 (H1N1) and A/Aichi/2/68 (H3N2) strains of influenza virus. Such HA-inhibitors are promising candidates for novel antiviral drugs.